Metraipolis › archive › dc_2e8feb932ae5

Dendritic cell maturation assay for non-clinical immunogenicity risk assessment: best practices recommended by the European Immunogenicity Platform — Europe PMC PMID:41346578

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41346578
DOI
10.3389/fimmu.2025.1704045
License (as archived)
solo-consultazione
Archived
2026-11-08T10:42:10.428Z
SHA-256 of the archived text
cee6b78fda6ef7ad300fdd521435e80ad56204083c35dc87da00fbff5500b88a
Stable URL of this page
https://metraipolis.com/documento/dc_2e8feb932ae5

How to cite

Dendritic cell maturation assay for non-clinical immunogenicity risk assessment: best practices recommended by the European Immunogenicity Platform — Europe PMC PMID:41346578 — Europe PMC (en), https://europepmc.org/article/MED/41346578 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2e8feb932ae5 (Metraipolis archive dc_2e8feb932ae5, sha256 cee6b78fda6ef7ad300fdd521435e80ad56204083c35dc87da00fbff5500b88a)
BibTeX
@misc{dc2e8feb932ae5,
  title = {Dendritic cell maturation assay for non-clinical immunogenicity risk assessment: best practices recommended by the European Immunogenicity Platform — Europe PMC PMID:41346578},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41346578},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2e8feb932ae5; sha256 cee6b78fda6ef7ad300fdd521435e80ad56204083c35dc87da00fbff5500b88a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41346578. Agents can read the archived copy with the MCP tool read_document.